Results 211 to 220 of about 4,685 (255)

Perioperative clinical outcomes of remimazolam in regional anesthesia: a systematic review of sedation and safety parameters. [PDF]

BMC Anesthesiol
Charmchi R, Khonakdar K, Bagheri N, Moradimajd P, Mirshekar M.   +4 more
europepmc   +1 more source

Awake intubation under light sedation with Remimazolam and remifentanil in a patient with trismus following maxillary gingival Cancer surgery: A case report

Rie Nishihara, Yusuke Ishida, Satoru Yaida, Rena Fukura, Tomomi Sasaki, Haruko Okazaki, Katsunori Oe   +6 more
openalex   +1 more source

Comparison of sedative effects between remimazolam and midazolam during HIFU for uterine fibroids: A prospective double-blind randomized trial

Haisu Fan, Bo Pang, Y X Jiang, Dunliang Wang   +3 more
openalex   +1 more source

Hypotension incidence comparison between remimazolam and propofol in hypertensive patients undergoing spinal surgery. [PDF]

Am J Transl Res
Cui J, Qi X, Wang J, Yao L.
europepmc   +1 more source

Erratum: Patient-Controlled Sedation with Remimazolam Enables More Precise Intraoperative Sedation in Elderly Patients Under Spinal Anesthesia: A Randomized Controlled Trial [Corrigendum]. [PDF]

Drug Des Devel Ther
europepmc   +1 more source

Is Remimazolam a Friend or Foe?

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Remimazolam

Advances in Anesthesia
Remimazolam is a new reversible γ-aminobutyric acid type A agonist benzodiazepine that displays a fast onset of action, short recovery time with a safe cardiopulmonary profile and favorable pharmacokinetics in comparison with other intravenous sedatives.
Miguel T, Teixeira, Abhinav, Goyal
  +5 more sources

An update on remimazolam and anaphylaxis

European Journal of Anaesthesiology, 2023
International ...
openaire   +3 more sources

Remimazolam: A Review in Procedural Sedation

Drugs, 2021
Remimazolam (Byfavo™) is a benzodiazepine sedative that is indicated for the induction and maintenance of procedural sedation in adults. Remimazolam was efficacious in three phase III trials in patients requiring endoscopies. Significantly higher procedure success rates (composite of the completion of the procedure, top-up doses of study drug within ...
Arnold Lee, Matt Shirley
openaire   +2 more sources

Remimazolam in neurosurgery

Current Opinion in Anaesthesiology
Purpose of review Remimazolam represents a novel intravenous anesthetic agent whose use began in 2020. As a new ultrashort-acting benzodiazepine, it has unique pharmacokinetic properties, such as remifentanil, designed to be active and easily transformed into inactive metabolites by tissue esterases.
Milena, Stojanovic, Radmilo, Jankovic
openaire   +2 more sources